Healthcare / Medical Instruments & SuppliesNasdaqGS
$66.18
-0.27 (-0.41%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $14.6M · quality 86.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
53/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$211M
P/E
19.6x
↓EV/EBITDA
8.9x
↓ROE
9.5%
↑Gross Margin
57.1%
↑Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+2.5%
FCF CAGR
+4.8%
FCF margin
37.2%
FCF / Net income
1.27x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $38.5M · net income $11.3M · FCF $14.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $38.5M | $38.5M | $40.9M | $50.2M | $52.3M | $49.1M | $42.2M | $46.9M | $42.0M | $41.4M | $39.3M | $40.2M | $41.3M | $40.5M | $41.6M | $37.9M | $25.1M | $25.9M |
| Net Income | $11.3M | $11.3M | $13.9M | $16.6M | $16.5M | $14.8M | $10.8M | $14.7M | $18.6M | $8.5M | $12.1M | $11.8M | $11.4M | $11.4M | $10.2M | $7.4M | $6.0M | $6.3M |
| EBITDA | $14.4M | $14.4M | $16.4M | $23.1M | $26.9M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS | 3.48 | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 | 2.94 | 3.94 | 4.95 | 2.28 | 3.22 | 3.14 | 3.02 | 3.02 | 2.74 | 2.03 | 1.65 | 1.72 |
| Gross Margin | 57.1% | 57.1% | 59.0% | 59.8% | 61.6% | 63.0% | 60.6% | 62.8% | 62.6% | 63.7% | 60.3% | 60.2% | 60.5% | 59.9% | 60.9% | 59.2% | 52.6% | 53.2% |
| Operating Margin | 29.6% | 29.6% | 33.2% | 33.4% | 37.9% | 38.5% | 32.5% | 37.6% | 44.5% | 45.9% | 41.2% | 39.0% | 39.3% | 36.6% | 36.6% | 31.3% | 35.5% | 36.4% |
| Net Margin | 29.3% | 29.3% | 33.9% | 33.1% | 31.5% | 30.1% | 25.6% | 31.4% | 44.2% | 20.5% | 30.9% | 29.5% | 27.6% | 28.2% | 24.5% | 19.6% | 23.9% | 24.1% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Current Ratio | 28.64 | 28.64 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $14.3M | $14.3M | $14.6M | $21.6M | $20.3M | $20.7M | $19.3M | $16.5M | $16.4M | $15.3M | $11.2M | $13.6M | $14.3M | $12.0M | $13.3M | $11.1M | $5.6M | $6.8M |
| Returns | ||||||||||||||||||
| ROE | 9.5% | 9.5% | 11.8% | 13.0% | 14.4% | 13.8% | 10.5% | 14.6% | 20.9% | 10.9% | 17.5% | 17.0% | 17.6% | 18.8% | 20.0% | 18.2% | 15.9% | — |
| Valuation | ||||||||||||||||||
| P/E | 19.58 | 19.58 | 15.49 | 17.68 | 21.94 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 8.94 | 8.94 | 8.04 | 8.71 | 10.67 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.80 | 1.80 | 1.83 | 2.29 | 3.16 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | -5.8% | -5.8% | -18.6% | -3.9% | — | 16.3% | -10.1% | 11.7% | 1.4% | 5.4% | -2.1% | -2.7% | 1.9% | -2.5% | 9.8% | 50.7% | -3.1% | — |
| EPS Growth | -12.1% | -12.1% | -13.4% | 1.1% | — | 37.4% | -25.4% | -20.4% | 117.1% | -29.2% | 2.5% | 4.0% | 0.0% | 10.2% | 35.0% | 23.0% | -4.1% | — |
| Dividend Yield | 1.9% | 1.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.1%
EPS terminal req.
$5.87
Spread vs growth
-31.2%
5Y implied EPS CAGR
15.3%
EPS terminal req.
$7.11
Spread vs growth
-27.5%
10Y implied EPS CAGR
12.6%
EPS terminal req.
$11.44
Spread vs growth
-24.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+22.0%
Start / end P/E
13.9x → 19.0x
EPS bridge
3.96 → 3.48
Residual
-4.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.